Skip to main content

Table 3 Distribution of biochemistry, clinical and lifestyle characteristics in relation to serum triglycerides in the CONOR survey

From: Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics

  Non-fasting trigycerides (mmol/L)
< 2.0 2.0-4.9 5.0-9.9 ≥ 10 Total
n % n % n % n % n %
Non-fasting serum glucose (mmol/L)
 < 7.0 103,889 94.5 35,527 88.0 2134 80.2 119 73.5 141,669 92.5
 7.0-8.9 4432 4.0 3065 7.6 262 9.8 16 9.9 7775 5.1
 9.0-10.9 855 0.8 759 1.9 95 3.6 2 1.2 1711 1.1
 ≥ 11.0 734 0.7 1006 2.5 170 6.4 25 15.4 1935 1.3
 Total 109,910 100.0 40,357 100.0 2661 100.0 162 100.0 153,090 100.0
Systolic blood pressure (mmHg)
 < 160 112,395 89.8 36,850 83.3 2376 81.5 149 86.1 151,770 88.0
 ≥ 160 12,715 10.2 7383 16.7 538 18.5 24 13.9 20,660 12.0
 Total 125,110 100.0 44,233 100.0 2914 100.0 173 100.0 172,430 100.0
Body mass index (kg/m2)
 < 20 6120 4.9 350 0.8 5 0.2 0 0.0 6475 3.8
 20.0-24.9 58,443 46.8 9791 22.2 339 11.7 16 9.2 68,589 39.9
 25.0-29.9 46,690 37.4 22,380 50.8 1464 50.5 85 49.1 70,619 41.1
 ≥ 30.0 13,501 10.8 11,506 26.1 1092 37.7 72 41.6 26,171 15.2
 Total 124,754 100.0 44,027 100.0 2900 100.0 173 100.0 171,854 100.0
Have had myocardial infarction
 Yes 3371 2.7 2193 5.0 146 5.1 10 5.8 5720 3.4
 No 120,420 97.3 41,489 95.0 2718 94.9 163 94.2 164,790 96.6
 Total 123,791 100.0 43,682 100.0 2864 100.0 173 100.0 170,510 100.0
Hard physical activity during one week
 No 38,733 36.5 15,432 43.0 1089 46.0 58 38.4 55,312 38.3
 < 1 h 26,506 25.0 9176 25.6 597 25.2 50 33.1 36,329 25.1
 1 - 2 h 26,371 24.8 7328 20.4 449 19.0 34 22.5 34,182 23.6
 ≥ 3 h 14,575 13.7 3917 10.9 233 9.8 9 6.0 18,734 13.0
 Total 106,185 100.0 35,853 100.0 2368 100.0 151 100.0 144,557 100.0
Daily smoking
 No 87,015 70.1 30,394 69.4 1862 64.7 89 51.4 119,360 69.8
 Yes 37,129 29.9 13,380 30.6 1016 35.3 84 48.6 51,609 30.2
 Total 124,144 100.0 43,774 100.0 2878 100.0 173 100.0 170,969 100.0